Exporter

EN
FR
Etoposide
Statut de médicament essentiel
Description générale
Etoposide is a plant alkaloid antineoplastic agent, used in treatment protocols for several types of cancer.
INN
Etoposide
Codes ATC
L01CB01
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté en 2015 (TRS 994) pour Germ cell tumour of testis
Ajouté en 2015 (TRS 994) pour Retinoblastoma
Ajouté en 2015 (TRS 994) pour Hodgkin lymphoma
Ajouté en 2021 (TRS 1035) pour Myeloid leukaemia
Wikipédia
Etoposide
DrugBank
Etoposide
Recommandations
Section
Cytotoxic medicines
  • Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule
  • Oral > Solid: 100 mg capsule
  • Parenteral > General injections > IV: 20 mg per mL in 5 mL ampoule; 100 mg in vial powder for injection (as phosphate)
  • Oral > Solid: 100 mg capsule; 50 mg capsule
Indications
Unspecified malignant neoplasms of ill-defined or unspecified sites Germ cell tumour of testis Malignant trophoblastic neoplasms of placenta Hodgkin lymphoma Other specified malignant neoplasms of bronchus or lung Other specified malignant neoplasms of the ovary Retinoblastoma Ewing sarcoma of bone and articular cartilage of unspecified sites Lymphoid leukaemia, not elsewhere classified Burkitt lymphoma including Burkitt leukaemia Myeloid leukaemia Malignant neoplasms of kidney, except renal pelvis Osteosarcoma of bone and articular cartilage of unspecified sites Anaplastic large cell lymphoma, ALK-positive Anaplastic large cell lymphoma, ALK-negative